Extend your brand profile by curating daily news.

PROTIA to Showcase Advanced Veterinary Diagnostic Technologies at WVC 2025

By FisherVista

TL;DR

PROTIA's Companion Animal & Equine Allergy Diagnostic Product Line offers a competitive edge in accurate allergen diagnosis for pets and horses.

The diagnostic products by PROTIA utilize advanced Parallel Line Array (PLA) system for rapid and precise allergen detection in animals.

PROTIA's innovative diagnostic technology improves animal health, increases survival rates, and reduces disease incidence, benefiting the well-being of animals worldwide.

Discover PROTIA's participation in WVC, showcasing cutting-edge animal diagnostic solutions to a global audience, aiming to enhance animal health and performance.

Found this article helpful?

Share it with your network and spread the knowledge!

PROTIA to Showcase Advanced Veterinary Diagnostic Technologies at WVC 2025

PROTIA, a leading developer of in-vitro diagnostic medical devices, is set to participate in the Western Veterinary Conference (WVC) 2025, showcasing innovative diagnostic technologies designed to enhance veterinary healthcare for companion and large animals.

The conference, taking place at the Mandalay Bay Convention Center in Las Vegas from March 2 to 5, will feature over 600 companies and an anticipated audience of more than 20,000 veterinary professionals worldwide. PROTIA's strategic presence aims to introduce advanced diagnostic solutions that could significantly improve animal health management and disease prevention.

The company will highlight three primary diagnostic products: 'ANITIA Canine/Feline IgE', 'ANITIA Equine IgE', and 'AniCheck Bovine/Equine IgG'. These technologies represent substantial advancements in veterinary diagnostic capabilities, offering rapid and precise allergen identification and immune health assessment.

The 'ANITIA Canine/Feline IgE' diagnostic kit enables veterinarians to quickly identify and understand potential allergic triggers in pets, facilitating more targeted treatment approaches. Similarly, the 'ANITIA Equine IgE' product allows for comprehensive allergy diagnosis in horses, utilizing a Parallel Line Array (PLA) system to screen 120 potential allergens through equine serum.

A particularly innovative offering is the 'AniCheck Bovine/Equine IgG', which measures immunoglobulin G concentrations in colostrum within just 10 minutes. This technology can potentially improve newborn animal survival rates by helping select high-quality colostrum rich in immune-supporting substances.

PROTIA's participation in WVC 2025 represents more than a product showcase; it signifies the company's commitment to advancing global veterinary healthcare through technological innovation. By presenting these diagnostic tools, PROTIA seeks to expand its international network and collaborate with veterinary professionals and companies dedicated to improving animal health.

The conference provides a critical platform for PROTIA to demonstrate how advanced diagnostic technologies can transform veterinary medicine, offering more precise, efficient, and comprehensive health management strategies for both companion and large animals.

Curated from 24-7 Press Release

blockchain registration record for this content
FisherVista

FisherVista

@fishervista